1. Breast cancer stage at diagnosis: Caucasians versus Afro-Americans

   • Arlene J. Zaloznik

   Report Pages: 195 - 198

2. Influence of n-3 fatty acids on the growth of human breast cancer cellsin vitro: Relationship to peroxides and Vitamin-E

   • Véronique Chajès
   • Wolfgang Sattler
   • Gert M. Kostner

   Report Pages: 199 - 212

3. Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: Immune phenomena or drug toxicity?

   • Gottfried J. Locker
   • Ingrid Simonitsch
   • Günther G. Steger

   Report Pages: 213 - 219

4. Estrogen receptors in 699 primary breast cancers: A comparison of immunohistochemical and biochemical methods

   • A. Molino
   • R. Micciolo
   • G. L. Cetto

   Report Pages: 221 - 228

5. Vasopressin gene related products are markers of human breast cancer

   • William G. North
   • Sara Pai
   • Vincent Memoli

   Report Pages: 229 - 235

6. Biological and clinical evaluation of Lanreotide (BIM 23014), a somatostatin analogue, in the treatment of advanced breast cancer

   • Angelo Di Leo
   • Leonardo Ferrari
   • Aldo Bono

   Report Pages: 237 - 244

7. CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer

   • Peter L. Devine
   • Maree A. Duroux
   • Clifford W. Pollard

   Report Pages: 245 - 251

8. Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer

   • J. Dirk Iglehart
   • Billie-Jo Kerns
   • Jeffrey R. Marks

   Report Pages: 253 - 263

9. Relationship of growth stimulated by lithium, estradiol, and EGF to phospholipase C activity in MCF-7 human breast cancer cells

   • Julia A. Taylor
   • Leigh H. Grady
   • Wade V. Welshons

   Report Pages: 265 - 277

10. Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients

    • Wolfram Jäger
    • Willi Sauerbrei

    Report Pages: 279 - 287